Gentrack share price higher on announcement of new CEO

The Gentrack Group Limited (ASX: GTK) share price is pushing higher today, following the announcement of the appointment of new CEO, Gary Miles.

| More on:
Silhouette of CEO standing in conference room looking out at cityscape.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Gentrack Group Limited (ASX: GTK) share price is pushing higher today, following the announcement of the appointment of new CEO Gary Miles.

At the time of writing, the Gentrack share price is trading at $1.47, up 1.03% compared with the All Ordinaries Index (ASX: XAO), which is up 1.51%.

What does Gentrack do?

Gentrack provides specialist software for energy utilities, water companies and airports, mainly in Australia and New Zealand. The company's platform aims to develop, integrate and support billing and customer management solutions.

What did management say?

Commenting on the new appointment, Gentrack acting chair Fiona Oliver said:

The Board is delighted to welcome Gary to the Gentrack business. He brings a real focus on driving global growth and building a workplace that fosters innovation, diversity and collaboration. His combined software and services experience with cloud technologies will also help to accelerate our transition to SaaS and deliver more value to customers and shareholders. 

Incoming CEO Gary Miles added:

The utility industry is entering a new era where regulatory, technology and environmental forces are accelerating the digital transformation of the market. Gentrack has been successful in helping service providers in some of the world's most dynamic markets and countries. I am excited to work with the Gentrack team to bring great, customer centric technologies to these and other service providers around the world.

Gary Miles' resume includes extensive experience in technology innovation and cloud capabilities, most notably serving on the leadership team of Amdocs Limited (NASDAQ: DOX) as chief marketing officer. Amdocs is a provider of cloud business software and services in the communications industry.

Miles' previous roles within the company included division president and CTO leading strategy development. This involved building the company's product portfolio and sales organisation as well as overseeing its digital services, big data and mobile engagement segments.

Gary Miles is expected to assume the CEO position on 1 October.

How has the Gentrack share price performed?

The Gentrack share price has struggled over the past 12 months. The technology company is 73% lower from its 52-week high of $5.50. However, the Gentrack share price is up 89% since its March low of 77 cents.

Should you invest?

Whilst this is a positive announcement and could be the start of good things to come, I think that there are better opportunities on the market at present. I will be watching Gentrack from the sidelines instead.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »